Continuation or deprescribing of proton pump inhibitors: A consult patient decision aid

Many patients continue on long-term proton pump inhibitor (PPI) therapy unnecessarily.1 Evidence-based guidance suggests attempting to reduce or stop PPIs in patients whose symptoms abate and have no indication for long-term use.2 Patients may therefore be faced with the decision to continue or reduce PPI use. Deprescribing is the planned, supervised dose reduction or stopping of a medication (for PPIs: lower dose or use “on demand” [as needed]). Patients are generally open to discussing ongoing PPI use; however, the decision to continue or reduce PPI use depends on preferences and values.3 Patients would like to be part of such discussions and planning surrounding ongoing PPI use.3,4 Thus, a structured tool to guide such a discussion would be helpful in clinical practice